Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Iradimed Cp (IRMD)

Iradimed Cp (IRMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 370,667
  • Shares Outstanding, K 12,565
  • Annual Sales, $ 41,810 K
  • Annual Income, $ 9,330 K
  • 60-Month Beta 1.05
  • Price/Sales 8.84
  • Price/Cash Flow 35.66
  • Price/Book 5.91
Trade IRMD with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.23
  • Number of Estimates 1
  • High Estimate 0.23
  • Low Estimate 0.23
  • Prior Year 0.20
  • Growth Rate Est. (year over year) +15.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.18 +4.68%
on 09/27/22
34.71 -15.01%
on 09/02/22
-3.01 (-9.26%)
since 08/26/22
3-Month
28.18 +4.68%
on 09/27/22
42.66 -30.85%
on 07/29/22
-4.92 (-14.29%)
since 06/27/22
52-Week
28.18 +4.68%
on 09/27/22
55.92 -47.25%
on 03/28/22
-4.76 (-13.89%)
since 09/27/21

Most Recent Stories

More News
3 Healthcare Stocks With High Profit Margins

If you want to invest in profitable healthcare companies in this bear market, these all look like good bets.

DOCS : 30.19 (-1.76%)
IRMD : 29.50 (+0.27%)
GILD : 62.63 (+0.47%)
IRadimed (IRMD) Beats Q2 Earnings and Revenue Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 12.50% and 0.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

IRMD : 29.50 (+0.27%)
MASI : 140.01 (-0.04%)
IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results

Reports second quarter 2022 revenue of $12.7 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.26Announces third quarter 2022 financial...

IRMD : 29.50 (+0.27%)
UPDATE - IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th

WINTER SPRINGS, Fla., July 28, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second...

IRMD : 29.50 (+0.27%)
IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th

WINTER SPRINGS, Fla., July 22, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second...

IRMD : 29.50 (+0.27%)
Perimeter Medical Imaging AI Appoints Experienced MedTech Executive, Chris Scott, as Chief Financial Officer

Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution,...

OTC.VN : 0.455 (unch)
IRMD : 29.50 (+0.27%)
PINK.VN : 1.680 (+2.44%)
PYNKF : 1.1900 (-1.65%)
IRADIMED Names John F. Glenn Chief Financial Officer

WINTER SPRINGS, Fla., May 26, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed...

IRMD : 29.50 (+0.27%)
After Plunging 27.4% in 4 Weeks, Here's Why the Trend Might Reverse for iRadimed (IRMD)

iRadimed (IRMD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings...

IRMD : 29.50 (+0.27%)
iRadimed (IRMD) is an Incredible Growth Stock: 3 Reasons Why

iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

IRMD : 29.50 (+0.27%)
Oversold Conditions For iRadimed (IRMD)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

IRMD : 29.50 (+0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump...

See More

Key Turning Points

3rd Resistance Point 31.66
2nd Resistance Point 30.70
1st Resistance Point 30.10
Last Price 29.50
1st Support Level 28.54
2nd Support Level 27.58
3rd Support Level 26.98

See More

52-Week High 55.92
Fibonacci 61.8% 45.32
Fibonacci 50% 42.05
Fibonacci 38.2% 38.78
Last Price 29.50
52-Week Low 28.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar